Immunome, Inc.
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoti…
Biotechnology
US, Exton [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Immunome, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDImmunome, Inc. can't present revenue by segment